News
Treventis Partners its Preclinical Program in Alzheimer’s Disease with Takeda
July 3, 2023
April 11, 2023 – Toronto, Ontario, Canada – Treventis Corporation, a privately held biotechnology company, announced today that it has…
Read More
Tech Update: A new approach to Alzheimer’s and proof that video calls are exhausting
April 27, 2023
Small Canadian biotech start-up Treventis is playing in the big leagues. The Toronto company just secured a partnership with Takeda, Japan’s largest…
Read More
The Pharma Letter: Takeda partners with Treventis on Alzheimer’s disease research
April 13, 2023
Japan’s largest drugmaker Takeda (TYO: 4502) has linked up with little-known Canadian biotech Treventis for the further research, development, and…
Read More
UHN: Takeda licenses small molecule developed by researchers at UHN’s Krembil Brain Institute, targeting tau protein implicated in Alzheimer’s disease
April 13, 2023
(Toronto, April 11, 2023) – As announced today in a press release by biotechnology company Treventis, global pharmaceutical company Takeda…
Read More
Endpoints News: Takeda joins forces with small private biotech for preclinical Alzheimer’s research
April 13, 2023
Takeda is wading deeper into Alzheimer’s disease research with a new preclinical collaboration announced Tuesday. The company will work with…
Read More
Treventis Partners its Preclinical Program in Alzheimer’s Disease with Takeda
April 11, 2023
April 11, 2023 – Toronto, Ontario, Canada – Treventis Corporation, a privately held biotechnology company, announced today that it has…
Read More
Treventis Awarded $2.97M Grant from the U.S. Department of Defense
October 18, 2022
Funds for Development of a Drug Against Neurodegenerative Diseases October 18, 2022 BERNVILLE, Pennsylvania – Treventis Corporation, a privately held…
Read More
Treventis founder Sultan Darvesh awarded Jubilee Medal
August 5, 2022
Treventis is pleased to congratulate our founder Dr. Sultan Darvesh, neurologist and Dalhousie professor, for being one of the first…
Read More
Treventis founders give invited lectures at WATOC
June 30, 2022
Treventis founders Donald Weaver and Christopher Barden are both invited speakers at the 12th Triennial Congress of the World Association…
Read More
Dr. Donald Weaver, Oskar Fischer Prize Winner
June 8, 2022
Congratulations to our own Dr. Donald Weaver, Treventis founder and Chief Medical Officer, for being an Oskar Fischer Prize winner!…
Read More